FABP2 and obesity due to melanocortin 4 receptor deficiency: Although FABP2 chaperonopathy is not firmly established as a carcinogenic factor in patients with colon cancer and hyperinsulinemia and obesity, this issue deserves further investigation, considering the possibility of applying chaperonotherapy to treat these very sick patients.